Incidence and predictors of loss to follow up among HIV-infected adults at Pawi General Hospital, northwest Ethiopia: Competing risk regression model

被引:42
作者
Assemie M.A. [1 ]
Muchie K.F. [2 ]
Ayele T.A. [2 ]
机构
[1] Department of Public Health, College of Health Sciences, Debre Markos University, Debre Markos
[2] Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar
关键词
ART; Associated factors; Competing risks regression; Cumulative incidence; Lost to follow-up; Predictors; Sub-distribution model;
D O I
10.1186/s13104-018-3407-5
中图分类号
学科分类号
摘要
Objective: This study was aimed at assessing the incidence of lost-to-follow-up and its predictors among HIV-positive adults after initiation into antiretroviral therapy at Pawi General Hospital, northwest Ethiopia. Results: The overall cumulative incidence of lost-to-follow-up after ART initiation was high, 11.6 (95% CI 9.8-13.7) per 100 adult-years follow-up time. Independent significant predictors of lost to follow up were being aged 15-28 years (aSHR = 0.44; 95% CI 0.24-0.83), being on WHO clinical stage IV (aSHR = 2.09; 95% CI 1.02-3.13); and receiving isoniazid preventive therapy (aSHR = 0.11; 95% CI 0.06-0.18). © 2018 The Author(s).
引用
收藏
相关论文
共 37 条
[1]  
US/HIV AIDS Report, (2015)
[2]  
HIV/AIDS Report, (2014)
[3]  
Federal Democratic Republic of Ethiopia, HIV/AIDS Prevention and Control Office, (2014)
[4]  
Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C., Kumarasamy N., Et al., Prevention of HIV-1 infection with early antiretroviral therapy, N Engl J Med, 365, 6, pp. 493-505, (2011)
[5]  
HIV/AIDS Fact Sheet, (2017)
[6]  
Estill J., Tweya H., Egger M., Wandeler G., Feldacker C., Johnson L.F., Et al., Tracing of patients lost to follow-up and HIV transmission: Mathematical modelling study based on two large ART programmes in Malawi, J Acquir Immune Defic Syndr (1999), 65, 5, (2014)
[7]  
Taiwo B., Understanding transmitted HIV resistance through the experience in the USA, Int J Infect Dis, 13, 5, pp. 552-559, (2009)
[8]  
Mberi M.N., Kuonza L.R., Dube N.M., Nattey C., Manda S., Summers R., Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: A cohort study, BMC Health Serv Res, 15, 1, (2015)
[9]  
Li M.S., Musonda P., Gartland M., Mulenga P.L., Mwango A., Stringer J.S., Et al., Predictors of patient attrition according to different definitions for loss to follow-up: A comparative analysis from Lusaka, Zambia, J Acquir Immune Defic Syndr (1999), 63, 3, (2013)
[10]  
Tadesse K., Fisiha H., Predictors of loss to follow up of patients enrolled on antiretroviral therapy: A retrospective cohort study, J AIDS Clin Res, 5, 393, (2014)